Jaime Bartushak
2021
In 2021, Jaime Bartushak earned a total compensation of $602.9K as Chief Financial Officer at Citius Pharmaceuticals, a 17% increase compared to previous year.
Compensation breakdown
| Bonus | $20,000 |
|---|---|
| Non-Equity Incentive Plan | $144,625 |
| Option Awards | $101,983 |
| Salary | $301,667 |
| Other | $34,636 |
| Total | $602,911 |
Bartushak received $301.7K in salary, accounting for 50% of the total pay in 2021.
Bartushak also received $20K in bonus, $144.6K in non-equity incentive plan, $102K in option awards and $34.6K in other compensation.
Rankings
In 2021, Jaime Bartushak's compensation ranked 10,304th out of 12,415 executives tracked by ExecPay. In other words, Bartushak earned more than 17.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,304 out of 12,415 | 17th |
Division Manufacturing | 4,566 out of 5,508 | 17th |
Major group Chemicals And Allied Products | 2,043 out of 2,378 | 14th |
Industry group Drugs | 1,812 out of 2,099 | 14th |
Industry Pharmaceutical Preparations | 1,344 out of 1,549 | 13th |
Source: SEC filing on December 20, 2021.
Bartushak's colleagues
We found three more compensation records of executives who worked with Jaime Bartushak at Citius Pharmaceuticals in 2021.
News
Citius Pharmaceuticals Chairman Myron Holubiak's 2022 pay falls 26% to $1.2M
December 22, 2022
Citius Pharmaceuticals CEO Myron Holubiak's 2021 pay jumps 91% to $1.7M
December 20, 2021
Citius Pharmaceuticals CEO Myron Holubiak's 2020 pay rises 15% to $875K
December 21, 2020
Citius Pharmaceuticals CEO Myron Holubiak's 2019 pay rises 12% to $764K
December 20, 2019
Citius Pharmaceuticals CEO Myron Holubiak's 2018 pay slips 2% to $681K
December 20, 2018